Orexigen Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Orexigen Therapeutics, Inc.
CIK #0001382911, 0001278906
EDGAR Form CIK 2011 - 2024
SC 13G [0001278906]
10-K [0001382911]
10-Q [0001382911]
3 [0001382911]
4 [0001382911]
8-K [0001382911]
D [0001382911]
SC 13D [0001382911]
SC 13G [0001382911]
Form 13D/13G Filer Form 13D/13G Subject Filed
UBS OConnor LLC Orexigen Therapeutics Inc [2018-02-13]
Nineteen77 Global Multi-Strategy Alpha Master Ltd Orexigen Therapeutics Inc [2018-02-12]
Man Group PLC Orexigen Therapeutics Inc [2017-12-01]
Telemetry Investments LLC Orexigen Therapeutics Inc [2017-08-03]
Biotechnology Value Fund L P Orexigen Therapeutics Inc [2016-07-19]
Baupost Group LLC/MA Orexigen Therapeutics Inc [2016-03-24]
Baupost Group LLC/MA Orexigen Therapeutics Inc [2015-10-09]
Foresite Capital Fund III LP Orexigen Therapeutics Inc [2015-08-04]
Price T Rowe Associates Inc /MD/ Orexigen Therapeutics Inc [2015-02-12]
FMR LLC Orexigen Therapeutics Inc [2014-02-14]
View All
Form 3/4/5 Subject 2011 - 2024
Orexigen Therapeutics, Inc.
Baupost Group LLC/MA
Klarman Seth A
Baupost Group GP, L.L.C.
Moglia Stephen A.
Forbes Monica
Flynn Peter D
Narachi Michael
Lynch Thomas P.
Keyes Jason A
View All
Terms | Privacy | Guide
tony@aum13f.com